-
-
Janssen Receives Positive CHMP Opinion for PONVORY™ ▼ (ponesimod) for RRMS
-
Posted in Industry News
-
29th Mar 2021
-
News from Janssen Pharmaceuticals
-
-
EPIDYOLEX® (cannabidiol) for treatment of seizures associated with Tuberous Sclerosis Complex
-
Posted in Industry News
-
03rd Mar 2021
-
News from GW Pharma
-
-
NeuroLifeNow App
-
Posted in Industry News
-
23rd Feb 2021
-
New App and website to support people with neurological conditions
-
-
BIAL takes the lead with Zebinix®
-
Posted in Industry News
-
18th Feb 2021
-
News from Bial regarding marketing and distribution of Zebinix®
-
-
SPRAVATO® (esketamine nasal spray) authorised in Europe
-
Posted in Industry News
-
11th Feb 2021
-
News from Janssen Pharmaceutical Companies of Johnson & Johnson
-
-
Zeposia Tablets Approved in Scotland to Treat Active RRMS
-
Posted in Industry News
-
10th Feb 2021
-
New oral treatment for MS to be available in Scotland
-
-
Holography ‘quantum leap’ could revolutionise imaging
-
Posted in Industry News
-
08th Feb 2021
-
News from the University of Glasgow
-
-
Jazz Pharma adds cannabis-based drug to its portfolio
-
Posted in Industry News
-
04th Feb 2021
-
News from Jazz Pharmaceuticals
-
-
NICE rejects Ozanimod (Zeposia) for RRMS
-
Posted in Industry News
-
26th Jan 2021
-
New of NICE appraisal
-
-
Plegridy® intramuscular administration for RRMS
-
Posted in Industry News
-
22nd Dec 2020
-
News from Biogen